Notably, in the last quinquennium, basal insulin was prescribed in association with DPP4i in 23.5% of T2D subjects, with GLP1-RA in 6.8%, and SGLT2i in 9.9% (Table 2). Here, INS is linked to type 2 diabetes mellitus.